TUCSON,
Ariz., Oct. 30, 2023 /PRNewswire/ -- Accelerate
Diagnostics, Inc. (NASDAQ: AXDX) announced today that management
will host a conference call on Thursday,
November 9, 2023, at 4:30 p.m.
Eastern Time to review 2023 third quarter results.
To listen to the audio webcast online, visit ir.axdx.com. A
replay of the audio webcast will be available for 30 days.
To listen by phone, dial +1.877.883.0383 and enter the Elite
Entry Number: 9121489. International participants may dial
+1.412.902.6506. Please dial in 10-15 minutes prior to the start of
the conference.
A replay of the call will be available by telephone at
+1.877.344.7529 (U.S.) or +1.412.317.0088 (International) using the
replay code 6290760 until November 30, 2023.
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is an in vitro diagnostics company
dedicated to providing solutions for the global challenges of
antibiotic resistance and sepsis. The Accelerate Pheno® system and
Accelerate PhenoTest® BC kit combine several technologies aimed at
reducing the time clinicians must wait to determine the most
optimal antibiotic therapy for deadly infections. The FDA cleared
system and kit fully automate the sample preparation steps to
report phenotypic antibiotic susceptibility results in
approximately 7 hours direct from positive blood cultures. Recent
external studies indicate the solution offers results 1-2 days
faster than existing methods, enabling clinicians to optimize
antibiotic selection and dosage specific to the individual patient
days earlier.
"Accelerate Diagnostics" and diamond shaped logos and marks are
registered trademarks of Accelerate Diagnostics, Inc. Any trade,
product or service name referenced in this document using the name
"Accelerate" is a trademark and/or property
of Accelerate Diagnostics, Inc. All other company and product names
may be trademarks, registered trademarks, or service marks of the
companies with which they are associated.
For more information about the company, its products and
technology, or recent publications, visit axdx.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accelerate-diagnostics-scheduled-call-to-review-2023-third-quarter-results-301970646.html
SOURCE Accelerate Diagnostics, Inc.